Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The use of whole immunoglobulin G (IgG) and F(ab')2 of the G-22 monoclonal antibody associated with cationic liposomes (immunoliposomes) and the effect of repeated exposure were investigated for the transfection of the LacZ gene to various
glioma
cell lines. Immunoliposomes associated with either whole IgG or F(ab')2 monoclonal antibody caused an about 2-fold increase in beta-galactosidase activity compared with liposomes associated with no antibody in
glioma
cell lines expressing the CD44 antigen.
beta-Galactosidase
activity was further increased by about 2-fold by repeated exposure compared with single exposure. A
glioma
cell line not expressing the CD44 antigen showed no such increase in beta-galactosidase activity. These results indicate that repeated exposure of cationic immunoliposomes achieves a higher transfection efficiency and is a potentially effective method of gene therapy for patients with malignant
glioma
.
...
PMID:Repeated exposure to cationic immunoliposomes activates effective gene transfer to human glioma cells. 886 48
A reporter gene (lac-z) was introduced into rat (BT4C) and human (D-54 MG) proliferating
glioma
cell lines by means of liposomal transfection. Lac-z-transfected
glioma
cells were first cultured as multicellular spheroids and then confronted with fetal brain aggregates. After various intervals the lac-z reporter gene product, bacterial beta-galactosidase, was histochemically detected in the cocultures.
beta-Galactosidase
was only detected in the
glioma
cells which showed an intense blue staining, which made them easily distinguishable from fetal tissue. Both
glioma
cell lines showed a clear pattern of migration and increasing invasion with time as the tumor cells infiltrated and destroyed the brain aggregates. Spheroid growth curves showed no significant differences between transfected and nontransfected cell lines. Likewise, flow cytometry measurements revealed no significant changes in ploidy between transfected and nontransfected rat
glioma
cells. In comparison, a shift in ploidy was observed in the human
glioma
cells after lac-z transfection. Stable integration of the lac-z gene into tumor cells was verified by Southern blot analysis. The results indicate that transfection of the lac-z reporter gene into
glioma
cells lines does not affect their growth or invasion potential in vitro. The lac-z reporter gene can thus be exploited to facilitate visualization of single migrating tumor cells and quantification of tumor invasion in in vitro coculture systems.
...
PMID:The lac-z reporter gene: a tool for in vitro studies of malignant glioma cell invasion. 918 46
Most brain tumors consist of transformed glia cells and are highly vascularized by capillary endothelial cells. The aim of the present study therefore was to deliver pro-apoptotic caspase-3 into malignant C6
glioma
and immortalized rBCEC4 brain endothelial cells to induce cell death. Both cell lines were transfected with a reporter protein (beta-galactosidase) using lipid-mediated gene transfer (FuGENE6) or using the novel protein delivery reagent BioPORTER.
beta-Galactosidase
protein was successfully delivered into both cells, the protein expression peaked around day 2 and was transient. Delivery of caspase-3 induced TUNEL-positive cell death of both cell types. As a control, caspase-3 was also delivered to non-neoplastic primary astrocytes and endothelial cells and induced cell death. In conclusion BioPORTER-protein delivery of pro-apoptotic molecules may provide a potent tool to cause death of the cells in brain tumors, however, this method is limited due to its toxicity to non-malignant cells.
...
PMID:Protein delivery of caspase-3 induces cell death in malignant C6 glioma, primary astrocytes and immortalized and primary brain capillary endothelial cells. 1569 Jan 27